이 콘텐츠들은 텔레위키가 직접 업로드하는 것이 아닌 유저들이 수집하고 게시하는 것입니다. 문제가 있는 경우 [email protected]로 연락 주시면 조치하겠습니다.
2025-07-29노보 노디스크, 예상보다 낮은 위고비 매출로 가이던스 하향
- 프리마켓 -20%
https://www.reuters.com/business/healthcare-pharmaceuticals/obesity-drugmaker-novo-nordisk-plunges-it-cuts-forecasts-again-2025-07-29/
Obesity drugmaker Novo Nordisk plunges as it cuts forecasts again | Reuters
"This is related to lower growth expectations for Wegovy in the U.S. obesity market, lower growth expectations for Ozempic in the U.S. GLP-1 diabetes market, as well as lower-than-expected penetration for Wegovy in select IO (International Operations) markets," it said.
- 프리마켓 -20%
https://www.reuters.com/business/healthcare-pharmaceuticals/obesity-drugmaker-novo-nordisk-plunges-it-cuts-forecasts-again-2025-07-29/
Obesity drugmaker Novo Nordisk plunges as it cuts forecasts again | Reuters
"This is related to lower growth expectations for Wegovy in the U.S. obesity market, lower growth expectations for Ozempic in the U.S. GLP-1 diabetes market, as well as lower-than-expected penetration for Wegovy in select IO (International Operations) markets," it said.